What is uniQure's EBITDA?

uniQure (QURE) reported EBITDA of -$42.76M in Q1 2026.

How has uniQure's EBITDA changed year-over-year?

uniQure's EBITDA decreased by 22.9% year-over-year, from -$34.8M to -$42.76M.

What is the long-term trend for uniQure's EBITDA?

Over 4 years (2021 to 2025), uniQure's EBITDA has grown at a -14.4% compound annual growth rate (CAGR), from $317.92M to -$170.59M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

uniQure QURE EBITDA

EBITDA at other companies

Ultragenyx PharmaceuticalRARE

-$161M-20.1%

Denali Therapeutics Inc.DNLI

-$134.51M+6.1%

PTC TherapeuticsPTCT

$60.37M-93.8%

CRISPR TherapeuticsCRSP

-$125.93M+12.4%

Apogee Therapeutics, Inc.APGE

-$82.36M-31.0%

Krystal Biotech, Inc.KRYS

——

Other financials

Income statement

See full

Revenue$3.6M+127%

Gross profit$3.3M+144%

Operating income-$45.7M-16.2%

Net income-$53.5M-22.7%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$140.0M-35.6%

Total debt$63.3M-4.3%

Total equity$149.3M+343%

Total assets$778.7M+28.6%

Cash flow

See full

Operating cash flow-$38.2M+13.3%

CapEx$140.0K+11.1%

Free cash flow-$38.4M+13.2%

Valuation

See full

Market cap$3.09B+78.4%

Enterprise value$3.02B+124%

P/S170.9×+85.1×

Profitability

See full

Gross margin90.6%-2.9pp

Operating margin-1,059.7%+380pp

Net margin-1,154.4%+89.3pp

FCF margin-953.7%+169pp

Returns & leverage

See full

Return on equity-228.2%-11.6pp

Debt / equity0.4×-1.5×

Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

−$45.7Mebit+

$3.0MDepreciation Depletion & Amortization

=-$42.76M

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is uniQure's EBITDA?: uniQure (QURE) reported EBITDA of -$42.76M in Q1 2026.
How has uniQure's EBITDA changed year-over-year?: uniQure's EBITDA decreased by 22.9% year-over-year, from -$34.8M to -$42.76M.
What is the long-term trend for uniQure's EBITDA?: Over 4 years (2021 to 2025), uniQure's EBITDA has grown at a -14.4% compound annual growth rate (CAGR), from $317.92M to -$170.59M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.